======= SRPK2 =======
== Gene Information ==
* **Official Symbol**: SRPK2
* **Official Name**: SRSF protein kinase 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6733|6733]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P78362|P78362]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=SRPK2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SRPK2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/602980|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Serine/arginine-rich protein-specific kinase which specifically phosphorylates its substrates at serine residues located in regions rich in arginine/serine dipeptides, known as RS domains and is involved in the phosphorylation of SR splicing factors and the regulation of splicing. Promotes neuronal apoptosis by up-regulating cyclin-D1 (CCND1) expression. This is done by the phosphorylation of SRSF2, leading to the suppression of p53/TP53 phosphorylation thereby relieving the repressive effect of p53/TP53 on cyclin-D1 (CCND1) expression. Phosphorylates ACIN1, and redistributes it from the nuclear speckles to the nucleoplasm, resulting in cyclin A1 but not cyclin A2 up- regulation. Plays an essential role in spliceosomal B complex formation via the phosphorylation of DDX23/PRP28. Can mediate hepatitis B virus (HBV) core protein phosphorylation. Plays a negative role in the regulation of HBV replication through a mechanism not involving the phosphorylation of the core protein but by reducing the packaging efficiency of the pregenomic RNA (pgRNA) without affecting the formation of the viral core particles. {ECO:0000269|PubMed:12134018, ECO:0000269|PubMed:16122776, ECO:0000269|PubMed:18425142, ECO:0000269|PubMed:18559500, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:21056976, ECO:0000269|PubMed:21157427, ECO:0000269|PubMed:9472028}.
|Pkinase|
|Pkinase Tyr|
|nuclear speck organization|
|nuclear body organization|
|14-3-3 protein binding|
|positive regulation of viral genome replication|
|positive regulation of neuron apoptotic process|
|spliceosomal complex assembly|
|negative regulation of viral genome replication|
|positive regulation of viral life cycle|
|negative regulation of viral life cycle|
|positive regulation of neuron death|
|regulation of viral genome replication|
|negative regulation of viral process|
|regulation of mRNA splicing, via spliceosome|
|positive regulation of viral process|
|nucleus organization|
|regulation of RNA splicing|
|regulation of mRNA processing|
|regulation of viral life cycle|
|regulation of viral process|
|regulation of neuron apoptotic process|
|magnesium ion binding|
|negative regulation of multi-organism process|
|regulation of symbiosis, encompassing mutualism through parasitism|
|ribonucleoprotein complex assembly|
|ribonucleoprotein complex subunit organization|
|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|
|mRNA splicing, via spliceosome|
|RNA splicing, via transesterification reactions|
|regulation of neuron death|
|angiogenesis|
|regulation of mRNA metabolic process|
|protein serine/threonine kinase activity|
|positive regulation of cell cycle|
|RNA splicing|
|blood vessel morphogenesis|
|ribonucleoprotein complex biogenesis|
|mRNA processing|
|blood vessel development|
|positive regulation of multi-organism process|
|vasculature development|
|cardiovascular system development|
|positive regulation of apoptotic process|
|positive regulation of programmed cell death|
|tube morphogenesis|
|mRNA metabolic process|
|positive regulation of cell death|
|innate immune response|
|regulation of multi-organism process|
|cellular protein-containing complex assembly|
|tube development|
|nucleolus|
|circulatory system development|
|RNA processing|
|anatomical structure formation involved in morphogenesis|
|positive regulation of cell population proliferation|
|defense response to other organism|
|protein phosphorylation|
|regulation of cell cycle|
|phosphorylation|
|response to other organism|
|response to external biotic stimulus|
|response to biotic stimulus|
|defense response|
|RNA binding|
|ATP binding|
|regulation of apoptotic process|
|protein-containing complex assembly|
|regulation of programmed cell death|
|regulation of cell population proliferation|
|RNA metabolic process|
|regulation of cell death|
|intracellular signal transduction|
|protein-containing complex subunit organization|
|immune response|
|positive regulation of gene expression|
|gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp528|TGF-beta1 44ng/ml R08 exp528]]|-1.88|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 6724
* **Expression level (log2 read counts)**: 5.45
{{:chemogenomics:nalm6 dist.png?nolink |}}